PsyRX CNS Bio-Tech Ltd (TLV:PSRX)
Israel · Delayed Price · Currency is ILS · Price in ILA 72.20
-2.10 (-2.83%)
At close: Aug 11, 2026
PsyRX CNS Bio-Tech Market Cap
PsyRX CNS Bio-Tech has a market cap or net worth of 7.38 million as of August 11, 2026. Its market cap has increased by 23.54% in one year.
Market Cap
7.38M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
72.20
ChartMarket Cap Chart
Since July 25, 2021, PsyRX CNS Bio-Tech's market cap has decreased from 329.34M to 7.38M, a decrease of -97.76%. That is a compound annual growth rate of -52.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 7.38M | -24.56% |
| Dec 31, 2025 | 9.79M | 100.78% |
| Dec 31, 2024 | 4.87M | -44.97% |
| Dec 31, 2023 | 8.86M | -64.09% |
| Dec 29, 2022 | 24.66M | -59.42% |
| Dec 30, 2021 | 60.77M | -81.55% |
| Jul 25, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 123.52B |
| Kamada | 1.24B |
| InterCure | 161.80M |
| Rekah Pharmaceutical Industry | 119.40M |
| Seach Medical Group | 85.97M |
| Together Pharma | 41.20M |
| Nextage Therapeutics | 13.14M |
| Tikun Olam-Cannbit Pharmaceuticals | 1.84M |